Home

Welcome to MyIDSA

Welcome to MyIDSA, IDSA’s Member-Only Community! Connect with Colleagues, Share Resources, Start or Join a Lively Discussion. Join us…It’s Infectious!

JOIN THE DISCUSSION

Recent Discussions

  • Posted in: HIV Community

    Wow! That's indeed an egregious amount to be charged... and clearly a hindrance. I personally have not had the same complaints from my PrEP patients with commercial insurance, which are the majority of my PrEP patients... however I am in NY so I'm sure ...

  • Posted in: IDea Exchange

    Given that we spend 2x other countries for comparable or worse outcomes, we should be skeptical about embracing costly therapies absent clinical studies demonstrating benefit. Mechanistic studies are great for generating hypotheses, but clinical data ...

  • Posted in: HIV Community

    Our Pediatric HIV clinic is developing an adolescent support group at our children's hospital. This is a significant need expressed by parents and our medical team.  Have any of you developed such a support group for ages 12-18? If so, how have you handled ...

New Guidelines Update

IDSA, ASTMH Neurocysticercosis Guideline

tapeworm 

Practice Guidelines

Member Spotlight

Kim Hanson, MD

IDSA Diagnostics Committee Chair Kim Hanson, MD, has been appointed to the Centers for Medicare and Medicaid (CMS) Advisory Panel on Clinical Diagnostic Laboratory Tests following a nomination from IDSA. The Panel advises the CMS Administrator and the Secretary of the Department of Health and Human Services on issues related to clinical diagnostic laboratory tests, including the establishment of payment rates and the factors used in determining coverage and payment processes for new tests.

Dr. Hanson is the head of Immunocompromised Host Infectious Diseases Services and Director of the Medical Microbiology Fellowship Program at the University of Utah, as well as Director of Clinical Microbiology at ARUP Laboratories. She is an associate professor of medicine and pathology, splitting her time between patient care, laboratory administration, research, and teaching.

News

  • Cure for common cold? 'Radical' treatment targets humans, not virus. And it works (so far)

    A new cold treatment could thwart the virus by leaving it alone and targeting humans instead.
  • WHO Essential Diagnostics List provides guide to tools needed for global health responses

    Tools to diagnose and monitor HIV, hepatitis B and C, and tuberculosis, as well as resistance to first-line TB treatment are among the tests ...

Help attract the best and brightest to the field of infectious diseases.

IDSA Foundation

Upcoming Events


  • Wednesday
    3
    October

    IDWeek 2018

    Wednesday, October 3 - Sunday, October 7, 2018
    Registration will open for members on March 6, and to everyone on April 3.
    San Francisco, CA, United States

IDSA has been important in my career in infectious disease. IDSA also plays a big role in advocacy and drawing attention to key issues. It's exciting to be a part of that and feel that I have an avenue for my voice to be heard.
Ingrid Bassett, MD, MPH, FIDSA
The idea that I could link epidemiology with my fundamental knowledge of how microorganisms work, along with diagnostic microbiology...this is an amazing way to put the pieces of the puzzles together about how infectious diseases work in human beings.
Lucy Tompkins, MD, PhD, FIDSA
I always like mystery stories growing up and you have to be very astute...You have to look at the symptoms, the geography, the home and social situation to solve the mystery of their problem.
Susan Bleasdale, MD
You can take a patient in front of you, and within a short amount of time with your clinical care, have an enormous impact.
John Lynch, MD, MPH
Understanding the pathogenesis of infectious diseases requires a knowledge of pathology, immunology, especially microbiology. The discipline allows practitioners to combine all of those, and there's never a dull moment.
Philip Polgreen, MD, MPH
I just became a member of IDSA this year, and I find it amazing how supportive IDSA has been to me so far.
Noah Kojima, MD